Fasting glucose normal range by age and risk zone

You walk in for a routine blood panel, fast overnight, and a few days later your portal pings: fasting glucose 95 mg/dL (5.3 mmol/L). Your doctor’s note says “within range.” That is true by American Diabetes Association diagnostic criteria. It also does not tell the whole metabolic story.

Fasting glucose is useful because it is cheap, standardized, and widely available. But a single value is a screening signal, not a full diagnosis of metabolic health. A result below 100 mg/dL is clinically normal. A result from 100-125 mg/dL meets the fasting-glucose criterion for prediabetes. A result of 126 mg/dL or higher generally needs confirmation on a separate day unless symptoms or unequivocal hyperglycemia are present.

For longevity and prevention, the useful question is not “Is this number normal once?” It is “Is this number stable over time, and does it match A1c, fasting insulin, triglycerides, body composition, sleep, training, and family history?”

Quick answer

The ADA diagnostic range for fasting plasma glucose is straightforward: below 100 mg/dL (5.6 mmol/L) is normal, 100-125 mg/dL (5.6-6.9 mmol/L) is prediabetes, and 126 mg/dL (7.0 mmol/L) or higher suggests diabetes when confirmed. Age does not create a separate official “normal” fasting-glucose range, but population glucose levels tend to rise with age. For prevention, repeated readings in the high-normal 90s are worth watching in context, especially if A1c, fasting insulin, waist circumference, triglycerides, or family history point the same direction.

Key facts

• Fasting glucose should be interpreted as venous plasma glucose after at least 8 hours without calories.
• ADA 2026 criteria classify fasting plasma glucose under 100 mg/dL as normal, 100-125 mg/dL as impaired fasting glucose/prediabetes, and 126 mg/dL or higher as diabetes when confirmed.
• A1c, fasting glucose, and 2-hour OGTT identify overlapping but not identical groups; one normal marker does not rule out early insulin resistance.
• NHANES data show median fasting glucose rises across broad adult age groups, but population averages are not prevention targets.
• People with prediabetes progress at different rates; lifestyle intervention in the Diabetes Prevention Program reduced diabetes incidence by 58% over about 3 years.
• Fasting glucose is included in PhenoAge-style biological-age models, but trends and context matter more than a single lab value.

What you’ll learn:

• What fasting glucose measures
• Reference range vs prevention-oriented risk zones
• How fasting glucose changes with age
• How to interpret your number
• Why fasting glucose alone is not enough
• How fasting glucose relates to biological age
• When to retest
• Frequently asked questions

---

What is fasting glucose?

Quick definition: Fasting glucose is the concentration of glucose in your bloodstream after at least 8-12 hours without food. It reflects how your liver, pancreas, muscle, and adipose tissue manage blood sugar at baseline — independent of any recent meal. It’s the cheapest, most universal metabolic biomarker and the entry point to almost every interpretation of insulin sensitivity, diabetes risk, and metabolic aging.

A standard fasting glucose draw measures plasma glucose after an overnight fast. The number reflects:

1. Hepatic glucose output — how much glucose your liver releases overnight
2. Insulin sensitivity — how well tissues respond to baseline insulin
3. Pancreatic β-cell function — whether your pancreas can keep glucose suppressed
4. Counter-regulatory hormones — cortisol, glucagon, growth hormone

When all four are working well, fasting glucose runs low and stable. When any of them drift — usually starting with insulin sensitivity in middle age — fasting glucose creeps up, often years before any other metabolic marker shifts.

This is why fasting glucose is one of the earliest, cheapest signals of metabolic aging. It’s also why interpreting it in isolation is one of the most common mistakes in routine bloodwork.

---

Reference range vs optimal range: Two different conversations

The ADA diagnostic framework for nonpregnant adults is:

Category	Fasting plasma glucose
Normal	< 100 mg/dL (< 5.6 mmol/L)
Prediabetes / impaired fasting glucose	100-125 mg/dL (5.6-6.9 mmol/L)
Diabetes	≥ 126 mg/dL (≥ 7.0 mmol/L), confirmed when hyperglycemia is not unequivocal

This framework is clinically validated for diagnosing diabetes and prediabetes. It is not designed to rank every “normal” value from best to worst.

For prevention, it is more accurate to use practical watch zones:

Practical zone	Fasting glucose	How to read it
Low or possibly under-fueled	< 70 mg/dL (< 3.9 mmol/L)	Discuss if symptomatic, on glucose-lowering medication, or recurrent
Lower normal	70-89 mg/dL (3.9-4.9 mmol/L)	Usually normal if you feel well
High-normal / watch trend	90-99 mg/dL (5.0-5.5 mmol/L)	Still ADA-normal; track trend and context
Prediabetes	100-125 mg/dL (5.6-6.9 mmol/L)	Follow up with A1c, repeat testing, and risk reduction
Diabetes range	≥ 126 mg/dL (≥ 7.0 mmol/L)	Needs clinical confirmation and physician-led management

Calling 95-99 mg/dL “practically prediabetic” is too strong. It is not prediabetes by ADA criteria. But repeated high-normal readings can still be useful early signals when they rise over time or appear alongside elevated A1c, fasting insulin, triglycerides, waist circumference, blood pressure, or family history.

For a broader view of how glucose fits into metabolic health and aging, read the complete guide.

---

Fasting glucose normal range by age

Age does not change the ADA diagnostic thresholds. A fasting glucose of 100-125 mg/dL is still prediabetes whether someone is 35 or 75.

What does change with age is the population distribution. In NHANES 2005-2010 data, median fasting plasma glucose was higher in older groups:

Age group	Median fasting plasma glucose in NHANES 2005-2010
18-39	94 mg/dL (5.2 mmol/L)
40-59	99 mg/dL (5.5 mmol/L)
60+	105 mg/dL (5.8 mmol/L)

Those are population medians, not targets. They include real-world patterns of body composition, medication use, undiagnosed dysglycemia, and lifestyle. They show why high-normal or prediabetic fasting glucose becomes more common with age, but they do not prove that higher glucose is harmless.

Practical age-aware interpretation

• Under 40: repeated fasting glucose in the 90s is still normal, but a rising trend deserves context if family history, triglycerides, waist circumference, or fasting insulin are also unfavorable.
• 40-60: focus less on one number and more on whether fasting glucose, A1c, insulin, and triglycerides are all drifting in the same direction.
• 60+: do not chase very low glucose, especially if frail or using glucose-lowering medication. But repeated values at or above 100 mg/dL still meet prediabetes criteria and deserve follow-up.

The prevention goal is not to force everyone into one narrow “optimal” band. It is to keep glycemia stable, avoid progression to prediabetes or diabetes, and catch insulin resistance early enough that lifestyle change still has high leverage.

---

Risk zones: How to interpret your number

Below 70 mg/dL (3.9 mmol/L)

This can be normal for some healthy people, but recurrent low fasting glucose, shakiness, sweating, confusion, or medication use should be discussed with a clinician. Lower is not always better.

70-89 mg/dL (3.9-4.9 mmol/L)

This is a lower-normal zone for many adults. If you feel well and other markers are normal, it is usually reassuring.

90-99 mg/dL (5.0-5.5 mmol/L)

This is still clinically normal by ADA criteria. The useful question is trend. A stable 94 mg/dL with normal A1c, normal fasting insulin, good triglycerides, and strong fitness is different from a value rising from 84 to 98 mg/dL over a decade while waist circumference and triglycerides rise.

If you are repeatedly in the high-normal 90s, consider targeted prevention: strength training, aerobic fitness, sleep regularity, body-composition work, and improving insulin sensitivity through training and sleep.

100-125 mg/dL (5.6-6.9 mmol/L)

This meets the fasting-glucose criterion for prediabetes. Progression is not inevitable. Reviews estimate that about 5-10% of people with prediabetes progress to diabetes each year, while a similar proportion may return to normoglycemia.

The Diabetes Prevention Program showed that intensive lifestyle intervention reduced diabetes incidence by 58% over about 3 years in high-risk adults. That is why this range should be treated as actionable, not as a label to ignore.

126 mg/dL or higher (7.0 mmol/L or higher)

This is in the diabetes diagnostic range when confirmed. In the absence of unequivocal hyperglycemia, ADA guidance calls for confirmatory testing. Fasting glucose alone does not tell you the full management picture; A1c, kidney markers, lipids, blood pressure, medication history, and sometimes CGM or OGTT matter.

---

Fasting glucose alone is not enough

Fasting glucose is the cheapest metabolic marker, but it’s also the least sensitive to early dysfunction. Many people develop meaningful insulin resistance with completely normal fasting glucose, because their pancreas is still able to compensate. That’s why interpreting glucose alone misses early signals.

The minimum metabolic panel for longevity-focused interpretation is:

Marker	What it adds
Fasting glucose	Baseline blood sugar
Fasting insulin	Insulin demand to maintain that glucose
HbA1c	3-month average glucose exposure
HOMA-IR	Calculated insulin resistance score
Triglycerides	Insulin resistance indirect signal

If your glucose is “fine” but insulin is creeping up, you have early-stage insulin resistance with compensated glucose — the most common missed pattern in routine bloodwork. For a result-in-hand interpretation of that exact discordance, see fasting glucose normal but insulin high. This is why comparing fasting insulin, HbA1c, and glucose head-to-head is more informative than reading any of them in isolation.

For the most accurate picture of glycemic control, a continuous glucose monitor adds detail that no fasting test can provide — postprandial spikes, overnight stability, glucose variability — all of which contribute to metabolic aging beyond the fasting number.

---

Fasting glucose and biological age

Fasting glucose matters for biological age because it reflects metabolic regulation, but it should not be overinterpreted from one draw.

PhenoAge includes glucose. The PhenoAge framework combines chronological age with clinical biomarkers, including glucose, albumin, creatinine, CRP, blood cell markers, and alkaline phosphatase. Higher glucose can push the estimate upward, but the model is a population-risk tool, not a diabetes diagnostic test.

Trend is more useful than a single value. A fasting glucose rising from the low 80s to the high 90s over years is a cleaner prevention signal than one isolated result. The trend becomes more meaningful when A1c, fasting insulin, triglycerides, waist circumference, and blood pressure drift with it.

Context prevents overreaction. Sleep loss, acute illness, stress, alcohol, late meals, hard training, medications, and sample handling can all affect a reading. Use fasting glucose as one input in a metabolic dashboard, not as a standalone verdict.

For background on the biomarker model, see PhenoAge and KDM biological age testing. For the broader glucose-aging relationship, see glucose, blood sugar, and aging.

---

When and how often to retest

Situation	Practical next step
Normal and low risk	Repeat at routine preventive intervals, often every 1-3 years depending on age and risk
High-normal 90s but stable	Recheck with A1c and cardiometabolic markers at the next routine panel
High-normal 90s and rising	Recheck in 3-6 months after lifestyle changes, or sooner if your clinician advises
100-125 mg/dL	Confirm and pair with A1c; discuss a prevention plan
126 mg/dL or higher	Repeat/confirm promptly unless hyperglycemia is unequivocal
Known diabetes	Follow your clinician’s plan, usually with A1c and/or CGM-based monitoring

Do not make a major decision from one borderline reading. Fasting glucose has biological and pre-analytical variability. A hard workout, poor sleep, illness, late eating, alcohol, steroid medication, or delayed sample processing can move the number. Repeated values in the same zone are more meaningful than a single surprise.

---

How SuperAge helps you track metabolic biomarkers

Reading fasting glucose once tells you almost nothing useful. Watching it across 5 years, paired with insulin, HbA1c, and your daily activity signals — that’s where metabolic aging becomes visible and actionable.

SuperAge simplifies this:

Longitudinal metabolic tracking

Instead of looking at fasting glucose in isolation, SuperAge integrates it with insulin, HbA1c, and your full biological age trajectory. You see whether your glucose regulation is drifting, stable, or improving — across years, not single panels.

Personalized risk-zone interpretation

SuperAge applies the longevity-aware risk zones — not just ADA cutoffs — so you see when your number is technically normal but practically drifting.

Apple Health and Apple Watch integration

Glucose trends become genuinely actionable when paired with daily signals: resting heart rate, HRV, sleep, training load. SuperAge connects your lab work with your daily biology.

Privacy-first

Your data stays on your device. Nothing is uploaded, sold, or shared.

---

Frequently asked questions

What is a normal fasting glucose level?

By ADA criteria, normal fasting plasma glucose is below 100 mg/dL (< 5.6 mmol/L). Prediabetes is 100-125 mg/dL, and diabetes is 126 mg/dL or higher when confirmed.

Is 95 mg/dL a good fasting glucose?

It is clinically normal. Whether it is reassuring depends on trend and context. A stable 95 mg/dL with normal A1c, normal fasting insulin, healthy waist circumference, and good fitness is different from a value rising steadily over years.

Does fasting glucose increase naturally with age?

Population averages rise with age, but age does not change ADA diagnostic thresholds. Higher average glucose in older populations reflects accumulated insulin resistance, medications, body-composition changes, and undiagnosed dysglycemia; it is not automatically a healthy target.

What fasting glucose should someone over 60 aim for?

There is no separate ADA “normal” cutoff for people over 60. Below 100 mg/dL remains clinically normal. Older adults should avoid both persistent hyperglycemia and unsafe hypoglycemia, especially if frail or taking glucose-lowering medication. Personal targets belong with a clinician.

Can fasting glucose be misleading?

Yes. Many people have normal fasting glucose while fasting insulin, A1c, post-meal glucose, triglycerides, or waist circumference already show metabolic strain. Pair fasting glucose with A1c and, when useful, fasting insulin, HOMA-IR, or CGM data.

---

Key takeaways

• ADA diagnostic thresholds are clear: normal is below 100 mg/dL, prediabetes is 100-125 mg/dL, and diabetes range starts at 126 mg/dL when confirmed.
• Age changes population averages, not official diagnostic cutoffs.
• High-normal values are not prediabetes, but repeated upward trends deserve context.
• Glucose alone is not enough: pair it with A1c, fasting insulin, triglycerides, waist circumference, and sometimes CGM.
• Prediabetes is actionable: structured lifestyle intervention can sharply reduce progression risk.

---

Start tracking your metabolic biomarkers today

A single fasting glucose value is a snapshot. Tracking it over years — paired with insulin, HbA1c, your daily activity, and your full biological age picture — is what actually moves the needle on metabolic longevity. The challenge isn’t getting the test. It’s interpreting the result over time, in context, against the right targets.

Ready to take control? Download SuperAge and start tracking fasting glucose and your other metabolic biomarkers as part of your full biological age picture.

---

A single borderline morning value is easier to interpret with fasting glucose high after poor sleep, especially when sleep, dinner timing, or training added noise.

References

1. American Diabetes Association. (2026). Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care. https://diabetesjournals.org/care/article/49/Supplement_1/S27/163926/2-Diagnosis-and-Classification-of-Diabetes
2. Centers for Disease Control and Prevention. Diabetes Testing. https://www.cdc.gov/diabetes/diabetes-testing/index.html
3. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes & Prediabetes Tests. https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/diabetes/diabetes-prediabetes
4. Menke A et al. (2014). Hemoglobin A1c, fasting plasma glucose, and 2-hour plasma glucose distributions in US population subgroups: NHANES 2005-2010. Annals of Epidemiology. https://pmc.ncbi.nlm.nih.gov/articles/PMC3946694/
5. Tirosh A et al. (2005). Normal fasting plasma glucose levels and type 2 diabetes in young men. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa050080
6. Tabák AG et al. (2012). Prediabetes: a high-risk state for diabetes development. The Lancet. https://pmc.ncbi.nlm.nih.gov/articles/PMC3891203/
7. Diabetes Prevention Program Research Group. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa012512
8. Levine ME et al. (2018). An epigenetic biomarker of aging for lifespan and healthspan. Aging. https://pmc.ncbi.nlm.nih.gov/articles/PMC5940111/

---

Last updated: 2026-06-08. This article is regularly reviewed to ensure accuracy. The information provided does not replace professional medical advice. Consult your healthcare provider before making decisions about testing or treatment.